Showing results (1-10 of 879) with videos related to

Sort By:
Pageof 88
Journal of Gastric Cancer|February 8, 2023
Recent Progress in Immunotherapy for Gastric CancerJeesun Yoon, Tae-Yong Kim, Do-Youn Oh
Expert Opinion on Biological Therapy|September 2, 2025
An evaluation of zanidatamab, a novel, anti-HER2 biparatopic antibody, for the treatment of biliary tract cancerJeesun Yoon, Do-Youn Oh
Nature Reviews. Clinical Oncology|July 22, 2024
HER2-targeted therapies beyond breast cancer - an updateJeesun Yoon, Do-Youn Oh
Cancer Research and Treatment|September 11, 2025
Analysis of T Cell Subsets Using Multiplex Immunohistochemistry and Clinical Outcomes of Immune Checkpoint Inhibitors in Advanced Gastric Cancer PatientsTae-Yong Kim, Jeesun Yoon, Dae-Won Lee, et al.
Scientific Reports|January 13, 2021
Prospective evaluation of metabolic intratumoral heterogeneity in patients with advanced gastric cancer receiving palliative chemotherapyShin Hye Yoo, Seo Young Kang, Jeesun Yoon, et al.
Expert Review of Gastroenterology & Hepatology|October 17, 2015
Capecitabine for the treatment of gastric cancerTae-Yong Kim, Do-Youn Oh, Yung-Jue Bang
Cancer Research and Treatment|August 6, 2021
Inhibition of WEE1 Potentiates Sensitivity to PARP Inhibitor in Biliary Tract CancerHye-Rim Seo, Ah-Rong Nam, Ju-Hee Bang, et al.
Oncogene|July 7, 2022
A synthetic lethal strategy using PARP and ATM inhibition for overcoming trastuzumab resistance in HER2-positive cancersKyoung-Seok Oh, Ah-Rong Nam, Ju-Hee Bang, et al.
Cancer Letters|June 3, 2021
ATR inhibition amplifies antitumor effects of olaparib in biliary tract cancerAh-Rong Nam, Jeesun Yoon, Mei-Hua Jin, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 16, 2021
WEE1 inhibition reverses trastuzumab resistance in HER2-positive cancersMei-Hua Jin, Ah-Rong Nam, Ju-Hee Bang, et al.
Pageof 88